Reading path
Reading the Evidence in Depression and Psychiatry
Psychiatric claims arrive wrapped in strong feelings and stronger headlines, from serotonin to psychedelics. This path teaches you to read the actual evidence behind depression care: what a symptom score means, how treatments are compared, and how to tell a robust finding from a hyped one. It is for curious readers and patients who want to weigh mental-health research on its merits.
The path, step by step
Start with what a symptom questionnaire does and does not capture, since every downstream trial rests on measurements like this.
Next, use the serotonin debate to learn how to read an umbrella review and its rebuttals rather than a slogan about chemical imbalance.
With mechanism in view, examine the time course of response to see how a widely repeated claim survives or fails against the data.
Move from single treatments to head-to-head comparisons, learning how comparative effectiveness evidence is built and read.
Scale that comparison up to many drugs at once, and see what a network meta-analysis can and cannot legitimately rank.
Apply the same appraisal lens to a popular non-drug option, where blinding and publication bias complicate a hopeful headline.
Shift from association to causation by reading how a randomized trial tests whether improving sleep actually changes mental health.
Bring these tools to the most hyped frontier, reading early psychedelic trials with attention to blinding and expectancy.
Close with stopping treatment, where receptor pharmacology explains why coming off a drug slowly is an evidence question too.
Each step is a full article on the Reading the Evidence blog.